167 related articles for article (PubMed ID: 2883873)
21. Central haemodynamic effects of beta blockers in hypertension. A comparison between atenolol, metoprolol, timolol, penbutolol, alprenolol pindolol and bunitrolol.
Lund-Johansen P
Eur Heart J; 1983 Jul; 4 Suppl D():1-12. PubMed ID: 6137366
[TBL] [Abstract][Full Text] [Related]
22. Pharmacology of combined alpha-beta-blockade. I.
Louis WJ; McNeil JJ; Drummer OH
Drugs; 1984; 28 Suppl 2():16-34. PubMed ID: 6151889
[TBL] [Abstract][Full Text] [Related]
23. Central hemodynamics of beta-adrenoceptor blocking drugs: beta 1 selectivity versus intrinsic sympathomimetic activity.
Svendsen TL
J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S21-5. PubMed ID: 6188916
[TBL] [Abstract][Full Text] [Related]
24. Haemodynamic effects of beta-adrenorecptor blockers in hypertension.
Ablad B; Ljung B; Sannerstedt R
Drugs; 1976; 11 SUPPL 1():127-34. PubMed ID: 6245
[TBL] [Abstract][Full Text] [Related]
25. Differences in betablocking drugs in cardiovascular therapy.
Iisalo E; Heikkilä J
Ann Clin Res; 1988; 20(5):324-33. PubMed ID: 2905877
[TBL] [Abstract][Full Text] [Related]
26. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
Wong GW; Laugerotte A; Wright JM
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
[TBL] [Abstract][Full Text] [Related]
27. Beta-blocking agents in patients with insulin resistance: effects of vasodilating beta-blockers.
Jacob S; Balletshofer B; Henriksen EJ; Volk A; Mehnert B; Löblein K; Häring HU; Rett K
Blood Press; 1999; 8(5-6):261-8. PubMed ID: 10803485
[TBL] [Abstract][Full Text] [Related]
28. Are we misunderstanding beta-blockers.
Cruickshank JM
Int J Cardiol; 2007 Aug; 120(1):10-27. PubMed ID: 17433471
[TBL] [Abstract][Full Text] [Related]
29. Hemodynamic effects of beta-blocking compounds possessing vasodilating activity: a review of labetalol, prizidilol, and dilevalol.
Lund-Johansen P
J Cardiovasc Pharmacol; 1988; 11 Suppl 2():S12-7. PubMed ID: 2464093
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological profile of beta-adrenoceptor blockers with vasodilating properties, especially carvedilol--rationale for clinical use.
Sponer G; Bartsch W; Strein K
Clin Investig; 1992; 70 Suppl 1():S20-6. PubMed ID: 1350480
[TBL] [Abstract][Full Text] [Related]
31. Beta-adrenoceptor blockade and vasodilatation in essential hypertension. Hemodynamic studies at rest and during exposure to stress.
Eggertsen R
Acta Med Scand Suppl; 1984; 689():1-46. PubMed ID: 6151343
[TBL] [Abstract][Full Text] [Related]
32. Relevance of intrinsic sympathomimetic activity for beta blockers.
Jaillon P
Am J Cardiol; 1990 Sep; 66(9):21C-23C. PubMed ID: 1977302
[TBL] [Abstract][Full Text] [Related]
33. Haemodynamic differences in untreated hypertension and hypertension treated with various beta-adrenoceptor antagonists.
Weil C; Waite R
Br J Clin Pharmacol; 1982; 13(Suppl 2):279S-283S. PubMed ID: 6125177
[TBL] [Abstract][Full Text] [Related]
34. Different patterns of peripheral versus central blood pressure in hypertensive patients treated with β-blockers either with or without vasodilator properties or with angiotensin receptor blockers.
Polónia J; Barbosa L; Silva JA; Bertoquini S
Blood Press Monit; 2010 Oct; 15(5):235-9. PubMed ID: 20577082
[TBL] [Abstract][Full Text] [Related]
35. Vasodilatory beta-blockers: systemic and regional hemodynamic effects.
Frohlich ED
Am Heart J; 1991 Mar; 121(3 Pt 2):1012-6; discussion 1016-7. PubMed ID: 1671725
[TBL] [Abstract][Full Text] [Related]
36. Beta-blockers in hypertension.
Hansson L
J Hypertens Suppl; 1987 Aug; 5(3):S61-7. PubMed ID: 2889813
[TBL] [Abstract][Full Text] [Related]
37. Basis for cardiovascular therapy with beta-blocking agents.
Opie LH
Am J Cardiol; 1983 Nov; 52(9):2D-9D. PubMed ID: 6139010
[TBL] [Abstract][Full Text] [Related]
38. Rationale for combined alpha-beta-adrenoceptor blockade: haemodynamic considerations.
Koch G
Acta Med Scand Suppl; 1982; 665():87-92. PubMed ID: 6130680
[TBL] [Abstract][Full Text] [Related]
39. Intrinsic sympathomimetic activity: clinical fact or fiction?
Taylor SH
Am J Cardiol; 1983 Nov; 52(9):16D-26D. PubMed ID: 6139009
[TBL] [Abstract][Full Text] [Related]
40. On the antihypertensive mechanisms of beta-adrenoceptor antagonists in relation to intrinsic sympathomimetic activity, cardioselectivity and hydrophilicity.
Man in't Veld AJ; Schalekamp MA
J Pharmacol; 1983; 14 Suppl 2():69-104. PubMed ID: 6138473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
